Ali Faraz 4
4 · Tenaya Therapeutics, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Tenaya (TNYA) CEO Ali Faraz Sells 3,390 Shares
What Happened
Ali Faraz, CEO of Tenaya Therapeutics (TNYA), reported a sale of 3,390 shares on 2026-05-18 at $0.79 per share, generating proceeds of $2,690. The filing indicates the sale was to cover tax withholding obligations tied to the vesting of restricted stock units (RSUs).
Key Details
- Transaction date: 2026-05-18; Filing date (Form 4): 2026-05-19 (appears timely).
- Transaction type/code: Sale (S) — open market or private sale; footnote F1: sale to cover tax withholding for vested RSUs awarded 2025-02-06.
- Price and proceeds: 3,390 shares × $0.79 = $2,690 (disposed).
- Footnote F2: Reporting person is scheduled to receive 321,581 shares upon vesting of RSUs (i.e., unvested awards that will convert to shares).
- No indication this was part of a 10b5-1 plan; transaction is described as tax-withholding related.
Context
This was a routine sale to satisfy tax withholding on vested RSUs rather than a discretionary portfolio sale. Such withholding sales are common and typically not read as a directional signal about the insider’s view of the company.
Insider Transaction Report
Form 4
Ali Faraz
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-18$0.79/sh−3,390$2,690→ 440,014 total
Footnotes (2)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
- [F2]Includes 321,581 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact|2026-05-19